Last reviewed · How we verify
hepatic artery infusion chemotherapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
hepatic artery infusion chemotherapy (hepatic artery infusion chemotherapy) — RenJi Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| hepatic artery infusion chemotherapy TARGET | hepatic artery infusion chemotherapy | RenJi Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- hepatic artery infusion chemotherapy CI watch — RSS
- hepatic artery infusion chemotherapy CI watch — Atom
- hepatic artery infusion chemotherapy CI watch — JSON
- hepatic artery infusion chemotherapy alone — RSS
Cite this brief
Drug Landscape (2026). hepatic artery infusion chemotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/hepatic-artery-infusion-chemotherapy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab